Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Fumaria parviflora* (Fine-leaved fumitory) is a medicinal herb in the family Fumariaceae that has been extensively utilized in Traditional Persian Medicine (TPM) and other traditional systems. It is characterized by a rich profile of bioactive secondary metabolites, most notably isoquinoline alkaloids such as sanguinarine, protopine, and fumaric acid. The plant exhibits multifaceted pharmacological properties, including anti-inflammatory, antioxidant, hepatoprotective, and bronchodilatory effects. Clinical research has investigated its efficacy in treating uremic pruritus in patients with end-stage renal disease and managing hot flashes in breast cancer survivors. Its mechanism of action involves the modulation of inflammatory cytokines (e.g., TNF-α, IL-6, and IFN-γ), the blockade of muscarinic receptors, and the inhibition of calcium influx into smooth muscle cells. Additionally, it has demonstrated potential in treating non-alcoholic fatty liver disease (NAFLD), male infertility related to varicocele, and various parasitic infections such as leishmaniasis and gastrointestinal helminthiasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fumaria parviflora.